These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17393059

  • 1. Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease.
    Unzeta M, Solé M, Boada M, Hernández M.
    J Neural Transm (Vienna); 2007; 114(6):857-62. PubMed ID: 17393059
    [Abstract] [Full Text] [Related]

  • 2. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
    Jiang ZJ, Richardson JS, Yu PH.
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):194-204. PubMed ID: 17971074
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia.
    Yu PH.
    Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Ferrer I, Lizcano JM, Hernández M, Unzeta M.
    Neurosci Lett; 2002 Mar 15; 321(1-2):21-4. PubMed ID: 11872247
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
    Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S, Kehoe PG.
    Neuropathol Appl Neurobiol; 2008 Apr 15; 34(2):181-93. PubMed ID: 17973905
    [Abstract] [Full Text] [Related]

  • 9. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M, Esteban-Lopez M, Taltavull B, Fábregas C, Fadó R, Casals N, Rodríguez-Álvarez J, Miñano-Molina AJ, Unzeta M.
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep 01; 1865(9):2189-2202. PubMed ID: 31047972
    [Abstract] [Full Text] [Related]

  • 10. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats.
    Somfai GM, Knippel B, Ruzicska E, Stadler K, Tóth M, Salacz G, Magyar K, Somogyi A.
    Neurochem Int; 2006 Jun 01; 48(8):746-52. PubMed ID: 16524643
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.
    Han BH, Zhou ML, Johnson AW, Singh I, Liao F, Vellimana AK, Nelson JW, Milner E, Cirrito JR, Basak J, Yoo M, Dietrich HH, Holtzman DM, Zipfel GJ.
    Proc Natl Acad Sci U S A; 2015 Feb 24; 112(8):E881-90. PubMed ID: 25675483
    [Abstract] [Full Text] [Related]

  • 13. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J, Jellinger KA, Lintner F.
    Acta Neuropathol; 2005 Sep 24; 110(3):222-31. PubMed ID: 16133541
    [Abstract] [Full Text] [Related]

  • 14. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M, Drukarch B, Hofstee M, Brevé J, Jongenelen CA, Bol JG, Wilhelmus MM.
    J Neurochem; 2015 Sep 24; 134(6):1116-28. PubMed ID: 26088696
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
    Unzeta M, Hernàndez-Guillamon M, Sun P, Solé M.
    Int J Mol Sci; 2021 Mar 25; 22(7):. PubMed ID: 33805974
    [Abstract] [Full Text] [Related]

  • 17. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
    Solé M, Unzeta M.
    Biol Cell; 2011 Nov 25; 103(11):543-57. PubMed ID: 21819380
    [Abstract] [Full Text] [Related]

  • 18. Patterns of cerebral amyloid angiopathy define histopathological phenotypes in Alzheimer's disease.
    Allen N, Robinson AC, Snowden J, Davidson YS, Mann DM.
    Neuropathol Appl Neurobiol; 2014 Feb 25; 40(2):136-48. PubMed ID: 23808763
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.